Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
4,098,087
-
Share change
-
-131,172
-
Total reported value
-
$13,112,972
-
Put/Call ratio
-
288%
-
Price per share
-
$3.20
-
Number of holders
-
34
-
Value change
-
-$296,661
-
Number of buys
-
13
-
Number of sells
-
11
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q2 2018
As of 30 Jun 2018,
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,098,087 shares.
The largest 10 holders included
FMR LLC, ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, STIFEL FINANCIAL CORP, Alethea Capital Management, LLC, Sio Capital Management, LLC, Opus Point Partners Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, and JPMORGAN CHASE & CO.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.